Manulife (Manufacturers Life Insurance)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.21M Sell
38,172
-11,768
-24% -$1.45M ﹤0.01% 1179
2026
Q1
$5.88M Sell
49,940
-7,162
-13% -$1M 0.01% 1089
2025
Q4
$9.41M Buy
57,102
+9,287
+19% +$1.45M 0.01% 903
2025
Q3
$6.39M Sell
47,815
-26,185
-35% -$3.18M 0.01% 1070
2025
Q2
$9.2M Buy
74,000
+10,947
+17% +$1.39M 0.01% 878
2025
Q1
$8.02M Sell
63,053
-1,146
-2% -$176K 0.01% 943
2024
Q4
$9.24M Sell
64,199
-2,468
-4% -$354K 0.01% 925
2024
Q3
$9.92M Sell
66,667
-1,034
-2% -$148K 0.01% 895
2024
Q2
$8.53M Buy
67,701
+2,946
+5% +$462K 0.01% 903
2024
Q1
$11.9M Buy
64,755
+2,116
+3% +$403K 0.01% 776
2023
Q4
$11.3M Sell
62,639
-1,177
-2% -$183K 0.01% 809
2023
Q3
$10.1M Buy
63,816
+7,468
+13% +$1.22M 0.01% 803
2023
Q2
$7.97M Buy
56,348
+282
+0.5% +$45.2K ﹤0.01% 876
2023
Q1
$9.44M Buy
56,066
+509
+0.9% +$90.8K 0.01% 819
2022
Q4
$9.43M Buy
55,557
+695
+1% +$126K 0.01% 817
2022
Q3
$10.3M Buy
54,862
+332
+0.6% +$70K 0.01% 778
2022
Q2
$8.89M Buy
54,530
+714
+1% +$113K 0.01% 858
2022
Q1
$10.1M Sell
53,816
-70,707
-57% -$13.4M 0.01% 900
2021
Q4
$33M Sell
124,523
-27,392
-18% -$7.38M 0.02% 486
2021
Q3
$43.9M Buy
151,915
+6,842
+5% +$1.76M 0.04% 408
2021
Q2
$29M Buy
145,073
+21,497
+17% +$4.17M 0.02% 524
2021
Q1
$24M Buy
123,576
+48,388
+64% +$9.92M 0.02% 569
2020
Q4
$14.4M Sell
75,188
-3,304
-4% -$601K 0.01% 740
2020
Q3
$11.6M Buy
78,492
+861
+1% +$123K 0.01% 738
2020
Q2
$9.24M Sell
77,631
-35,617
-31% -$4.19M 0.01% 812
2020
Q1
$10.9M Buy
113,248
+3,578
+3% +$345K 0.01% 698
2019
Q4
$10.1M Sell
109,670
-3,347
-3% -$281K 0.01% 826
2019
Q3
$8.66M Buy
113,017
+83,794
+287% +$7.33M 0.01% 899
2019
Q2
$2.51M Buy
29,223
+3,724
+15% +$254K ﹤0.01% 1329
2019
Q1
$1.51M Buy
25,499
+1,453
+6% +$83.6K ﹤0.01% 1505
2018
Q4
$1.27M Sell
24,046
-1,420
-6% -$83.3K ﹤0.01% 1500
2018
Q3
$1.41M Sell
25,466
-3,795
-13% -$196K ﹤0.01% 1597
2018
Q2
$1.38M Buy
29,261
+920
+3% +$37.9K ﹤0.01% 1674
2018
Q1
$1.02M Sell
28,341
-701
-2% -$24.7K ﹤0.01% 1827
2017
Q4
$1.05M Buy
29,042
+669
+2% +$24.2K ﹤0.01% 1816
2017
Q3
$1.09M Buy
28,373
+1,971
+7% +$82.6K ﹤0.01% 1735
2017
Q2
$1.09M Buy
26,402
+106
+0.4% +$4.03K ﹤0.01% 1756
2017
Q1
$926K Buy
26,296
+3,167
+14% +$100K ﹤0.01% 1783
2016
Q4
$712K Buy
23,129
+90
+0.4% +$2.78K ﹤0.01% 1878
2016
Q3
$695K Sell
23,039
-26
-0.1% -$785 ﹤0.01% 1860
2016
Q2
$631K Buy
23,065
+1,371
+6% +$35.1K ﹤0.01% 1887
2016
Q1
$581K Buy
21,694
+233
+1% +$5.7K ﹤0.01% 1907
2015
Q4
$607K Buy
21,461
+226
+1% +$6.52K ﹤0.01% 1906
2015
Q3
$592K Buy
21,235
+555
+3% +$20.1K ﹤0.01% 1890
2015
Q2
$854K Sell
20,680
-333
-2% -$12.2K ﹤0.01% 1779
2015
Q1
$638K Buy
21,013
+572
+3% +$14.8K ﹤0.01% 1949
2014
Q4
$405K Sell
20,441
-617
-3% -$13.8K ﹤0.01% 2134
2014
Q3
$420K Buy
21,058
+179
+0.9% +$3.77K ﹤0.01% 2094
2014
Q2
$476K Sell
20,879
-3,480
-14% -$62K ﹤0.01% 2073
2014
Q1
$314K Sell
24,359
-794
-3% -$11.4K ﹤0.01% 2405
2013
Q4
$343K Buy
25,153
+926
+4% +$11.1K ﹤0.01% 2318
2013
Q3
$269K Sell
24,227
-15
-0.1% -$149 ﹤0.01% 2431
2013
Q2
$200K Buy
+24,242
New +$204K ﹤0.01% 2560

Other funds holding RGEN

Manulife (Manufacturers Life Insurance)'s RGEN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Repligen (RGEN) stake by 24% in Q2 2026, selling an estimated $1.45M and leaving 38,172 shares worth $5.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Manulife (Manufacturers Life Insurance) first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.9M in Q3 2021. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 38,172 shares of Repligen worth $5.21M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 11,768 Repligen shares in Q2 2026, an estimated $1.45M.
  • Repligen made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1179 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Repligen position peaked at $43.9M in Q3 2021.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.